Literature DB >> 11237128

Placentation, antiphospholipid syndrome and pregnancy outcome.

S Stone1, M A Khamashta, L Poston.   

Abstract

The antiphospholipid antibodies (aPLs) are a diverse group of autoantibodies associated with a pattern of disease known as antiphospholipid syndrome (APS). Pregnancy complications secondary to placental insufficiency are key features of this disease. The mechanisms underlying the placental pathology remain unclear. In this article the process of placentation in healthy and pathological pregnancies is reviewed. The evidence for defective placentation in APS pregnancies and involvement of aPLs in this process is summarized. Finally hypotheses based on the interpretation of these studies are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11237128     DOI: 10.1191/096120301667486047

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

1.  Multiple immune disorders in unrecognized celiac disease: a case report.

Authors:  Giorgio La Villa; Pietro Pantaleo; Roberto Tarquini; Lino Cirami; Federico Perfetto; Francesco Mancuso; Giacomo Laffi
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

Review 2.  Antiphospholipid syndrome: multiple mechanisms.

Authors:  C G Mackworth-Young
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

3.  Antiphospholipid Syndrome during pregnancy: the state of the art.

Authors:  Fosca A F Di Prima; Oriana Valenti; Entela Hyseni; Elsa Giorgio; Marianna Faraci; Eliana Renda; Roberta De Domenico; Santo Monte
Journal:  J Prenat Med       Date:  2011-04

Review 4.  Potential use of statins in the treatment of antiphospholipid syndrome.

Authors:  Chary Lopez-Pedrera; Patricia Ruiz-Limon; M Angeles Aguirre; Antonio Rodriguez-Ariza; Maria José Cuadrado
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

Review 5.  [Systematic lupus erythematosus and antiphospholipid syndrome during pregnancy].

Authors:  G Ruiz-Irastorza; M A Khamashta
Journal:  Z Rheumatol       Date:  2006-05       Impact factor: 1.372

6.  Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro.

Authors:  N Di Simone; E Raschi; C Testoni; R Castellani; M D'Asta; T Shi; S A Krilis; A Caruso; P L Meroni
Journal:  Ann Rheum Dis       Date:  2004-07-15       Impact factor: 19.103

Review 7.  Anti-phospholipid antibodies and infertility.

Authors:  H J A Carp; Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

Review 8.  Celiac disease and obstetrical-gynecological contribution.

Authors:  Giovanni Casella; Guido Orfanotti; Loredana Giacomantonio; Camillo Di Bella; Valentina Crisafulli; Vincenzo Villanacci; Vittorio Baldini; Gabrio Bassotti
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016

9.  Pathogenesis of Antiphospholipid Syndrome.

Authors:  Borut Bo Ic
Journal:  EJIFCC       Date:  2004-08-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.